Smruthi Organic

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE172E01011
  • NSEID:
  • BSEID: 540686
INR
130.05
13.7 (11.77%)
BSENSE

Aug 10

BSE+NSE Vol: 62.37 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Smruthi Organic
Bal Pharma
Godavari Drugs
Lactose (India)
Tyche Industries
Pharmaids Pharma
Auro Labs.
Balaxi Pharma
Kimia Bioscien.
Krebs Biochem
Guj. Inject(Ker)
Why is Smruthi Organics Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of -4.22% and Operating profit at -22.92% over the last 5 years
2
Flat results in Mar 26
  • NET SALES(Latest six months) At Rs 51.38 cr has Grown at -25.90%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -12.22% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Smruthi Organic should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Smruthi Organic for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Smruthi Organic
-8.06%
-0.24
51.89%
Sensex
-1.65%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-4.22%
EBIT Growth (5y)
-22.92%
EBIT to Interest (avg)
6.40
Debt to EBITDA (avg)
0.85
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.64
Tax Ratio
26.32%
Dividend Payout Ratio
48.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.46%
ROE (avg)
7.42%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
18
Industry P/E
37
Price to Book Value
1.98
EV to EBIT
12.43
EV to EBITDA
8.10
EV to Capital Employed
1.90
EV to Sales
1.35
PEG Ratio
0.14
Dividend Yield
1.18%
ROCE (Latest)
8.63%
ROE (Latest)
10.75%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
PAT(9M)

Higher at Rs 4.92 Cr

-3What is not working for the Company
NET SALES(Latest six months)

At Rs 51.38 cr has Grown at -25.90%

Loading Valuation Snapshot...
Here's what is working for Smruthi Organic
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 4.92 Cr
than preceding 12 month period ended Mar 2026 of Rs 3.39 cr
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)

Here's what is not working for Smruthi Organic
Net Sales - Latest six months
At Rs 51.38 cr has Grown at -25.90%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)